Using a Novel CDST to Guide the Assessment and Management of Low-/High-Risk Ulcerative Colitis

Clinical care pathways, based on extensive research, provide clear guidance on escalation of therapy for patients with mild ulcerative colitis (UC); however, in patients with moderate-to-severe UC, the selection of treatment is less clear. Recently a clinical decision support tool (CDST) has been developed using key clinical imaging and laboratory markers. This tool is specifically designed for patients with high burden of disease – namely those at high risk of colectomy. The tool assesses disease burden, uses risk and clinical/laboratory data to predict outcomes for certain drugs, and includes additional resources explaining how the prediction is calculated. Join Dr. Dubinsky in a virtual demonstration of the tool using patient case vignettes.